Epidemiologist stresses COVID-19 pathophysiologic research
chinadaily.com.cn |
Updated: 2020-03-19 08:00
Share
Share - WeChat
More research should be done on the overreaction of the immune response in COVID-19 disease, said Zhong Nanshan, China's leading epidemic control expert, in a recent video talk.
Zhong also noted that once the patients deteriorate, the survival rate is pretty low, as some of the pathophysiologic characteristics are different from usual cases of ARDS, or acute respiratory distress syndrome.
Zhong shared China's experience in the fight against the coronavirus with Dr. Anita Simonds, the president-elect of the European Respiratory Society, in an online conversation earlier this month.
- Linqing: Where Grand Canal meets culinary crossroads
- Xi puts forward five-point proposal for building Asia-Pacific community
- Xi urges Asia-Pacific to jointly bolster universally beneficial, inclusive development
- Xi proposes Asia-Pacific jointly promote digitalization, greening of trade
- Xi says China not to close door to the outside world, will only open still wider
- Xi calls on APEC to jointly keep industrial, supply chains stable, smooth
